Portal de Periódicos da CAPES

Ethanol‐Inducible Cytochrome P450 (CYP2E1): Biochemistry, Molecular Biology and Clinical Relevance: 1996 Update

1996; Wiley; Volume: 20; Issue: s8 Linguagem: Inglês

10.1111/j.1530-0277.1996.tb01764.x

1530-0277

Byoung‐Joon Song, Arthur I. Cederbaum,

Lipid metabolism and biosynthesis

Alcoholism: Clinical and Experimental ResearchVolume 20, Issue s8 p. 138a-146a Ethanol-Inducible Cytochrome P450 (CYP2E1): Biochemistry, Molecular Biology and Clinical Relevance: 1996 Update B.J. Song, B.J. Song Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, USASearch for more papers by this authorArthur I. Cederbaum, Arthur I. Cederbaum Department of Biochemistry, Mount Sinai Hospital Medical School, New York, NY, USASearch for more papers by this author B.J. Song, B.J. Song Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, USASearch for more papers by this authorArthur I. Cederbaum, Arthur I. Cederbaum Department of Biochemistry, Mount Sinai Hospital Medical School, New York, NY, USASearch for more papers by this author First published: November 1996 https://doi.org/10.1111/j.1530-0277.1996.tb01764.xCitations: 119AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat SELECTED REFERENCES 1 Lieber CS, DeCarli LM: Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 162: 917–918, 1968. 2 Lieber CS, DeCarli LM: Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. J Biol Chem 245: 2505–2512, 1970. 3 Guengerich FP, Kim DH, Iwasaki M: Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4: 168–179, 1991. 4 Koop DR: Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6: 724–730, 1992. 5 Koop DR, Casazza JP: Identification of ethanol-inducible isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J Biol Chem 260: 13607–13612, 1985. 6 Hardwick JP, Song BJ, Huberman E, Gonzalez FI: Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid ω-hydroxylase. J Biol Chem 262: 801–810, 1987. 7 Laethem RM, Balazy M, Falck, JR. Laethem, CL, Koop DR: Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-nducible cytochrome P450 2E1. J Biol Chem 268: 12912–12918, 1993. 8 Amet Y, Berthou F, Goasduff T., Salaun JP, Le Breton L, Menez JF: Evidence that cytochrome P450 2E1 in involved in the (ω-1) hydroxylation of lauric acid in rat liver microsomes. Biochem Biophys Res Commun 203: 1168–1174, 1994. 9 Laethem RM, Laethem CL, Koop DR: Purification and properties of a cytochrome P450 arachidonic acid epoxygenase from rabbit renal cortex. J Biol Chem 267: 5552–5559, 1992. 10 Vaz ADN, Roberts ES, Coon, MJ: Reductive ß-scission of the hydroperoxides of fatty acids and xenobiotics: Role of alcohol-inducible cytochrome P-450. Proc Natl Acad Sci USA 87: 5499–5503, 1990. 11 Bestervelt LL, Vaz ADN, Coon MJ: Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans- 4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation. Proc Natl Acad Sci USA 92: 3764–3768, 1995. 12 Ardies CM, Lasker JM, Lieber CS: Characterization of the cytochrome P450-dependent monooxygenase system of hamster liver microsomes: effects of prior treatment with ethanol and other xenobiotics. Biochem Pharmacol 36: 3613–3619, 1987. 13 Reinke LA, Lau EK, DuBose CM, McCay PB: Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: Correlation with radical formation in vitro. Proc Natl Acad Sci USA 84: 9223–9227, 1987. 14 Behrens UJ, Hoerner M, Lasker JM, Lieber CS: Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo. Biochem Biophys Res Commun 154: 584–590, 1988. 15 Behrens UJ, Ma X-L, Bychenok S, Baraona E, Lieber CS: Acetaldehyde-collagen adducts in CCU-induced liver injury in rats. Biochem Biophys Res Commun 173: 111–119, 1990. 16 Braun KP, Cody, RBJr., Jones, DR, Peterson CM: A structural assignment for a stable acetaldehyde-lysine adduct. J Biol Chem 270: 11263–11266, 1995. 17 Smith SL, Jennett RB, Sorrell MF, Tuma DJ: Substoichiometric inhibition of microtubule formation by acetaldehyde-tubulin adducts. Biochem Pharmacol 44: 65–72, 1992. 18 Lin RC, Smith RS, Lumeng L: Detection of a protein-acetaldehyde adduct in the liver of rats fed alcohol chronically. J Clin Invest 81: 615–619, 1988. 19 Song BJ, Gelboin HV, Park SS, Yang CS, Gonzalez FJ: Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s: transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem 261: 16689–16697, 1986. 20 Khani SC, Zaphiropoulos PG, Fujita VS, Porter TD, Koop DR, Coon MJ: cDNA and derived amino acid sequences of ethanol-inducible rabbit liver cytochrome P-450 isozyme 3a (P-450alc). Proc Natl Acad Sci USA 84: 638–642, 1987. 21 Koop DR, Tierney DJ: Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessay 12: 429–435, 1990. 22 Porter TD, Coon MJ: Cytochrome P-450: Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266: 13469–13472, 1991. 23 Song BJ: Gene structure and multiple regulations of the ethanol-inducible cytochrome P450 2E1 (CYP2E1) subfamily, in RR Watson (ed): Alcohol and Hormones, vol 6. Totowa , NJ , Humana Press, 1995, p 177. 24 Ronis MJJ, Lindros KO, Ingelman-Sundberg M: The cytochrome P4502E1 subfamily, in I Ioannides (ed): Cytochromes P450, Pharmacological and Toxicological Aspects. Boca Raton , FL , CRC Press, 1996 (in press). 25 Gonzalez FJ: The molecular biology of cytochrome P450s. Pharmacol Rev 40: 243–288, 1989. 26 Yun YP, Sohn DH, Casazza JP, Veech RL, Song BJ: Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet. Mol Pharmacol 41: 474–479, 1991. 27 Song BJ, Veech RL, Park SS, Gelboin HV, Gonzalez FJ: Induction of rat hepatic N-nitrosodimelhylamine demethylase by acetone is due to protein stabilization. J Biol Chem 264: 3568–3572, 1989. 28 Eliasson E, Johansson I, Ingelman-Sundberg M: Ligand-dependent maintenance of ethanol-inducible cytochrome P-450 in primary hepatocyte cell culture. Biochem Biophys Res Commun 150: 436–443, 1988. 29 Tsutsumi M, Lasker JM, Takahashi T, Lieber CS: In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis. Arch Biochem Biophys 304: 209–218, 1993. 30 Eliasson E, Mkrtchian S, Ingelman-Sundberg M: Hormone- and substrate-regulated intracellular degradation of cytochrome P450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes. J Biol Chem 267: 15765–15769, 1992. 31 Ronis MJJ, Huang J, Crouch J, Mercado C, Irby D, Valentine CR, Lumpkin CK, Ingelman-Sundberg M, Badger TM: Cytochrome P450 CYP2E1 induction during chronic alcohol exposure occurs by a two step mechanism associated with blood alcohol concentrations in rats. J Pharmacol Exp Ther 264: 944–950, 1993. 32 Badger TM, Huang J, Ronis M, Lumpkin CK: Induction of cytochrome P450HII1 during chronic ethanol exposure occurs via transcription of the CYP2E1 gene when blood alcohol concentrations are high. Biochem Biophys Res Commun 190: 780–785, 1993. 33 McGehee, REJr., Ronis, MJJ, Cowherd RM, Ingelman-Sundberg M, Badger TM: Characterization of cytochrome P450–2E1 induction in a rat hepatoma FGC-4 cell model by ethanol. Biochem Pharmacol 48: 1823–1833, 1994. 34 Roberts BJ, Shoaf SE, Jeong KS, Song BJ: Induction of CYP2E1 in liver, kidney, brain, and intestine during chronic ethanol administration and withdrawal: Evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem Biophys Res Commun 205: 1064–1071, 1994. 35 Roberts BJ, Shoaf SE, Song BJ: Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats. Biochem Pharmacol 49: 1665–1673, 1995. 36 Roberts BJ, Song BJ, Soh Y, Park SS, Shoaf SE: Ethanol induces CYP2E1 by protein stabilization: Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem 270: 29632–29635, 1995. 37 Zerilli A, Lucas D., Amet Y, Beauge F, Volant A, Floch HH, Berthou F, Menez J-F: Alcohol Alcohol 30: 357–365, 1995. 38 Tierney DJ, Haas AL, Koop DR: Degradation of cytochrome P4502E1: Selective loss after labilization of the enzyme. Arch Biochem Biophys 293: 9–16, 1992. 39 Roberts BJ: Unpublished observation. 40 Barmada S, Kienle E, Koop DR: Rabbit P450 2E1 expressed in CHO-K1 cells has a short half life. Biochem Biophys Res Commun 206: 601–607, 1995. 41 Dai Y, Cederbaum AI: Inactivation and degradation of human cytochrome P4502E1 by CCl4 in a transfected HepG2 cell line. J Pharmacol Exp Ther 275: 1614–1622, 1995. 42 Correia MA, Davoll SH, Wrighton SA, Thomas PE: Degradation of rat liver cytochrome P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1, 4-dihydropyridine: Characterization of the proteolytic system. Arch Biochem Biophys 297: 228–238, 1992. 43 Ronis MJJ, Johansson I, Hultenby K, Lagercrants J, Glaumann H, Ingelman-Sundberg M: Acetone-regulated synthesis and degradation of cytochrome P4502E1 and cytochrome 2B1 in rat liver. Eur J Biochem 198: 383–389, 1991. 44 Robin M-A, Maratrat M, Loeper J, Durand-Schneider A-M, Tinel M, Ballet F, Beaune P, Feldmann G, Pessayre D: Cytochrome P4502B follows I vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology 108: 1110–1123, 1995. 45 Neve EPA, Eliasson E, Pronzato MA, Albano E, Marinari U, Ingelman-Sundberg M: Enzyme specific transport of a rat liver cytochrome P450 to the Golgi apparatus. Arch Biochem Biophys (in press). 46 Wu D, Cederbaum AI: Presence of functionally active cytochrome P-450IIE1 in the plasma membrane of rat hepatocytes. Hepatology 15: 515–524, 1992. 47 Takase S, Matsuda Y, Yasuhara M, Takada A: Effects of malotilate treatment on alcohol liver disease. Alcohol 6: 219–222, 1989. 48 Hu Y, Mishin V, Johansson I, von Bahr C, Cross A, Ronis MIJ, Badger TM, Ingelman-Sundberg M: Chlormethiazole as an efficient inhibitor of cytochrome P4S02E1 expression in rat liver. J Pharmacol Exp Ther 269: 1286–1291, 1994. 49 Jeong KS, Lee IJ, Roberts BJ, Soh Y, Ryu JK, Lee JW, Song BJ: Transcriptional inhibition of cytochrome P4502E1 (CYP2E1) by a synthetic compound, YH439. Arch Biochem Biophys 326: 137–144c, 1996. 50 Kim SG, Kwak JY, Lee JW, Novak RF, Park SS, Kim ND: Malotilate, a hepatoprotectant, suppresses CYP2E1 expression in rats. Biochem Biophys Res Commun 200: 1414–1420, 1994. 51 Lee IJ, Jeong KS, Roberts BJ, Kallarakal AT, Fernandez-Salguero P, Gonzalez FJ, Song BJ: Transcriptional induction of the cytochrome P4501 Al gene by a thiazolium compound, YH439. Mol Pharmacol 49: 980–988, 1996. 52 Liu S-Y, Gonzalez FJ: Role of the liver-enriched transcription factor HNF-1α in expression of the CYP2E1 gene. DNA Cell Biol 14: 285–293, 1995. 53 Yoo, J-SH, Ning SM, Pantuck CB, Pantuck EJ, Yang CS: Regulation of hepatic microsomal cytochrome P450UE1 level by dietary lipids and carbohydrates in rats. J Nutr 121: 959–965, 1991. 54 de Waziers I, Garlatti M, Bouquet J, Beaune PH, Barouki R: Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcrip-tional level in the rat hepatoma cell line. Mol Pharmacol 47: 474–479, 1995. 55 Sokoloff L: Metabolism of the central nervous system in vivo, in J Field, HW Magoun, VE Hall (ed): Handbook of Physiology: Neurophysiology, vol 3. Washington , DC Am Physiol Soc, 1960, p 1843. 56 Casazza JP, Sohn DH, Park KS, Song BJ: Serum acetone and liver acetone monooxygenase activity in pregnant rats, fetuses, and neonates: Reversible pretranslational reduction of cytochrome P450IIE1 (P450IIE1) during pregnancy. Arch Biochem Biophys 309: 111–116, 1994. 57 Wu D, Cederbaum AI: Induction of liver cytochrome P4502E1 by pyrazole and 4-melhylpyrazole in neonatal rats. J Pharmacol Exp Ther 264: 1468–1473, 1993. 58 Wu D, Cederbaum AI: Expression of cytochrome P4502E1 in rat fetal hepatocyte culture. Mol Pharmacol 49: 802–807, 1996. 59 Carpenter SP, Lasker JM, Raucy JL: Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol Pharmacol 49: 260–268, 1996. 60 Jones SM, Boobis AR, Moore GE, Stainer P: Expression of CYP2E1 during fetal development: Methylation of the CYP2E1 gene in human fetal and adult liver samples. Biochem Pharmacol 43: 1876–1879, 1992. 61 Hakkola O, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Maenpaa J, Rane A, Raunio H: Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 48: 59–64, 1994. 62 de Waziers I, Bouguet J, Beaune PH, Gonzalez FJ, Barouki R: Effects of ethanol, dexamethasone and RU486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase pi in a rat hepatoma cell line (Fao). Pharmacogenetics 2: 12–18, 1992. 63 Goasduff T, Menez JF, Dreano Y, Berthou F: CYP1A2 and 2E1 expression in rat liver treated with combined inducers (3-methylcholanthrene and ethanol). Biochem Biophys Res Commun 211: 497–503, 1995. 64 Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliasson E, Clot P, Albano E: Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10: 447–452, 1993. 65 Lucas D, Menez C, Girre C, Berthou F, Bodenez P, Joannet I, Hispard E, Bardou L-G, Menez J-F: Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5: 298–304, 1995. 66 Hayashi S, Watanabe J, Kawajiri K: Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome NS0IIE1 gene. J Biochem 110: 559–565, 1991. 67 Tsutsumi M, Takase S, Takada A: Genetic factors related to the development of carcinoma in digestive organs in alcoholics. Alcohol Alcohol 28(S1B): 21–26, 1993. 68 Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Abe, T. Satoh, K, Motomiya M, Watanabe M: Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer. Pharmacogenetics 4: 58–63, 1994. 69 Hirvonen A, Husgafvel-Pursiaiene K, Anttila S, Karjalainen AN, Vainio H: The human CYP2E1 gene and lung cancer: Dra I and Rsa I restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 14: 85–88, 1993. 70 Carr LG, Hartlerroad JY, Liang Y, Mendenhall C, Moritz T, Homasson HT: Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol Clin Exp Res 19: 182–184, 1995. 71 Ball DM, Sherman D, Gibb R, Powell JF, Hillman A, Peters T, Murray R, Smith I: No association between the c2 allele at the cytochrome P450IIE1 gene and alcohol induced liver disease, alcohol Korsakoff's syndrome or alcohol dependence syndrome. Drug Alcohol Depend 39: 181–184, 1995. 72 Carr LG, Yi IS, Li T-K, Yin S-J: Cytochrome P4502E1 genotypes, alcoholism, and alcoholic liver cirrhosis in Han Chinese and Atayal native of Taiwan. Alcohol Clin Exp Res 20: 43–46, 1996. 73 Maezawa Y, Yamauchi M, Toda G, Suzuki H, Sakurai S: Alcohol-metabolizing enzyme polymorphisms and alcoholism in Japan. Alcohol Clin Exp Res 19: 951–954, 1995. 74 Ingelman-Sundberg M: (submitted for publication). 75 Cederbaum AI: Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radic Biol Med 7: 537–539, 1989. 76 Ekstrom G, Cronholm T, Ingelman-Sundberg M: Hydroxyl-radical production and ethanol oxidation by liver microsomes isolated from ethanol-treated rats. Biochem J 233: 755–761, 1986. 77 Puntarulo S, Cederbaum AI: Increased NADPH-dependent chemiluminescence by microsomes after chronic ethanol consumption. Arch Biochem Biophys 266: 435–445. 1988. 78 Ekstrom G, Ingelman-Sundberg M: Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38: 1313–1319, 1989. 79 Rashba-Step J, Turro, NG. Cederbaum, AI: Increased NADPH- and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Arch Biochem Biophys 300: 401–408, 1993. 80 Nordblom GD, Coon MJ: Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P450. Arch Biochem Biophys 180: 343–347, 1977. 81 Kukielka E, Cederbaum AI: DNA strand cleavage as a sensitive assay for the production of hydroxyl radicals by microsomes: role of cytochrome P4502E1 in the increased activity after ethanol treatment. Biochem J 302: 773–779, 1994. 82 Ingelman-Sundberg M, Johansson I, Penttila KE, Glaumann M, Lindros KO: Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver. Biochem Biophys Res Commun 157: 55–60, 1988. 83 Tsutsumi M, Lasker J, Shimizu M, Rosman AS, Lieber CS: The interlobular distribution of ethanol-inducible P4502E1 in rat and human liver. Hepatology 10: 437–446, 1989. 84 Kukielka E, Cederbaum AI: Increased production of hydroxyl radical by pericentral microsomes compared to periportal microsomes after pyrazole induction of cytochrome P4502E1. Biochem Biophys Res Commun 215: 698–705, 1995. 85 Ross AD, Varghese G, Oporto B, Carmichael FJ, Israel Y: Effect of propylthiouracil treatment on NADPH-cytochrome P450 reductase levels, oxygen consumption and hydroxyl radical formation in the liver microsomes from rats fed ethanol or acetone chronically. Biochem Pharmacol 49: 979–989, 1995. 86 Aisen P, Listowsky I: Iron transport and storage proteins. Ann Rev Biochem 49: 357–393, 1980. 87 Thomas CE, Aust SD: Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls. J Biol Chem 261: 13064–13070, 1986. 88 Kukielka E, Cedeibaum AI: Ferritin stimulation of lipid peroxidation by microsomes after chronic ethanol treatment: role of cytochrome P4502E1. Arch Biochem Biophys (in press). 89 Tsukamoto H, Towner SJ, Ciofalo LH, French SW: Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 6: 814–822, 1986. 90 Tsukamoto H, French SW: Introduction: Evolution of intragastric ethanol infusion model. Alcohol 10: 439–441, 1993. 91 Morimoto M, Hagbjork A-L, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, Albano E, French SW: Role of cytochrome P4502E1 in alcoholic liver disease. Alcohol 10: 459–464, 1993. 92 Nanji AA, Zhao S, Lamb RG, Sadrzadeh SSH, Dannenberg AJ, Waxman DJ: Changes in microsomal phospholipases and arachidonic acid in experimental alcoholic liver injury: Relationship to cytochrome P-450 2E1 induction and conjugated diene formation. Alcohol Clin Exp Res 17: 598–603, 1993. 93 Femandez-Checa IC, Hirano T, Tsukamoto H, Kaplowitz N: Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol 10: 469–475, 1993. 94 Nanji AA, Zhao S, Sadrzadeh SMH, Dannenberg AJ, Tahan SR, Waxman DJ: Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol Clin Exp Res 18: 1280–1285, 1994. 95 Morimoto M, Zem MA, Hagbjork AL, Ingelman-Sundberg M, French SW: Fish oil, alcohol, and liver pathology: Role of cytochrome P4502E1. Proc Soc Exp Biol Med 207: 197–205, 1994. 96 Nanji AA, Khwaja, S. Tahan, SR, Sadrzadeh SMH: Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver injury. J Pharmacol Exp Ther 269: 1280–1285, 1994. 97 Nanji AA, Zhao S, Khwaja S, Sadrzadeh SMH, Waxman DJ: Cimetidine prevents alcoholic hepatic injury in the gastric feeding rat model. J Pharmacol Exp Ther 269: 832–837, 1994. 98 Morimoto M, Reitz RC, Morin RJ, Nguyen K, Ingelman-Sundberg M, French SW: CYP-2E1 inhibits partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet. J Nutr 125: 2953–2964, 1995. 99 Nanji AA, Yang EK, Fogt F, Sadrzadeh SMH, Dannenberg AJ: Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther 277: 1694–1700, 1996. 100 Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F, Meydani M, Dannenberg AJ: Dietary saturated fatty acids: A novel treatment for alcoholic liver disease. Gastroenterology 109: 547–554, 1995. 101 Ma X, Zhao J, Lieber CS: Polyenylphosphatidylcholine attenuates nonalcoholic hepatic fibrosis and accelerates its regression. J Hepatol 24: 604–613. 1996. 102 Reyes E, Ott S, Robinson B: Effects of in utero administration of alcohol on glutathione levels in brain and liver. Alcohol Clin Exp Res 17: 877–881, 1993. 103 Masini A, Ceccarelli D, Gallesi D, Giovannini F, Trenti T: Lipid hydroperoxide induced mitochondrial dysfunction following acute ethanol intoxication in rats: The critical role for mitochondrial reduced glutathione. Biochem Pharmacol 47: 217–224, 1994. 104 Parola M, Leonarduzzi G, Biasi F, Albano E, Biocca ME, Poli G, Dianzani, ML: Vitamin E supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology 16: 1014–1021, 1992. 105 Moncada C, Torres V, Varghese G, Albano E, Israel Y: Ethanol-derived immunoreactive species formed by free radical mechanisms. Mol Pharmacol 46: 786–791, 1994. 106 Israel Y, Hurwitz E, Niemela O, Arnon R: Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 83: 7923–7927, 1986. 107 Israel Y, MacDonald A, Niemela O, Zamel D, Shami E, Zywulko M, Klajner F, Borgono C: Hypersensitivity to acetaldehyde-protein adducts. Mol Pharmacol 42: 711–717, 1992. 108 Hoemer M, Behrens UJ, Worner T, Lieber CS: Humoral immune response to acetaldehyde adducts in alcoholic patients. Res Commun Chem Pathol Pharmacol 54: 3–12, 1986. 109 Worrall S, DeJersey J, Shanley BC, Wilce PA: Ethanol induces the production of antibodies to acetaldehyde-modified epitopes in rats. Alcohol Alcohol 24: 217–223, 1989. 110 French SW, Wong K, Jui L, Albano E, Hagbjork AL, Ingelman-Sundberg M: Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology. Exp Mol Pathol 58: 61–75, 1993. 111 Clot P, Bellomo G, Tabone M, Arico S, Albano E: Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology 108: 201–207, 1995. 112 Clot, P. Albano, E, Eliasson E, Tabone M, Arico S, Israel Y, Moncada C, and Ingelman-Sundberg M: Cytochrome P4502E1 hydroxyethyl radical adducts as the major autoantigen in autoantibody formation among alcoholics. Gastroenterology 111: 206–216, 1996. 113 Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW: Role of cytochrome P4502E1 -dependent formation of hydroxyethyl radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23: 155–163, 1996. 114 Pohl LR: Drug-induced allergic hepatitis. Semin Liver Dis 10: 305–315, 1990. 115 Eliasson E, Kenna G: Cytochrome P4502E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol (in press). 116 Bourdi M, Chen W, Peter RM, Martin JL, Buters JTM, Nelson SD, Pohl LR: Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol (in press). 117 Wu D, Cederbaum AI: Combined effects of streptozotocin-induced diabetes plus 4-methylpyrazole treatment on rat liver cytochrome P4502E1. Arch Biochem Biophys 302: 175–182, 1993. 118 Pessayre D, Wandscheer JC, Cobert B, Level R, Dogott C, Batt AM, Martin N, Benhamou JP: Additive effects of inducers and fasting on acetaminophen hepatotoxicity. Biochem Pharmacol 29: 2219–2223, 1980. 119 Liu PT, Symons AM, Parke DV: Autoxidation injury with loss of cytochrome P-450 following acute exposure of rats to fasting and ether anesthesia. Xenobiotica 21: 205–215, 1991. 120 Lee SST, Buters JTM, Pineau T, Femandez-Salguero P, Gonzalez FJ: Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271: 12063–12067, 1996. Citing Literature Volume20, Issues8November 1996Pages 138a-146a ReferencesRelatedInformation